Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exalpha Biologicals is a life science tools and antibody-reagents company focused on supplying research-use products rather than developing therapeutic drug candidates. Its catalog includes antibodies, proteins, peptides, BrdU cell proliferation assay kits, FIX&PERM flow-cytometry reagents, control lysates, sera, and custom IgY-related offerings. The company historically operated from Shirley, Massachusetts, and expanded its reagent portfolio through the 2018 acquisition of Gallus Immunotech. Exalpha later became part of the Nordic-MUbio/LSBio roll-up and is now presented as one of the brands within Absolute Biotech. Overall, Exalpha appears to function as a commercial bioreagents brand serving academic and biopharma research customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Exalpha Biologicals.